What should patients be monitored for after taking Risperidone?

After taking Risperidone, patients should be monitored for hyperglycaemia due to the medication's potential side effects on glucose metabolism. Risperidone is an atypical antipsychotic that can lead to weight gain and an increased risk of metabolic syndrome, which includes hyperglycaemia as a significant concern. This risk is particularly relevant for individuals with pre-existing conditions such as diabetes or those who are predisposed to developing metabolic disorders.

Monitoring for hyperglycaemia is essential because elevated blood sugar levels can lead to severe complications if not addressed promptly. Patients may require regular blood glucose checks, especially during the initial treatment phase and as the dosage is adjusted. Awareness of these metabolic side effects helps healthcare providers manage and mitigate potential risks associated with long-term therapy with Risperidone, ensuring better overall management of the patient's health.